Relevant Studies on Cytokines Level and CAR-T Expansion Associated to CD7 CAR-T Therapy

被引:0
|
作者
Wang, Dongchu [1 ]
Wang, Hui [1 ]
机构
[1] Hebei Yanda Lu Daopei Hosp, Langfang, Peoples R China
关键词
D O I
10.1182/blood-2023-180843
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Optimizing CAR-T Therapy for Glioblastoma
    Oliver Y. Tang
    Zev A. Binder
    Donald M. O’Rourke
    Stephen J. Bagley
    Molecular Diagnosis & Therapy, 2023, 27 : 643 - 660
  • [22] Optimizing CAR-T Therapy for Glioblastoma
    Tang, Oliver Y.
    Binder, Zev A.
    O'Rourke, Donald M.
    Bagley, Stephen J.
    MOLECULAR DIAGNOSIS & THERAPY, 2023, 27 (06) : 643 - 660
  • [23] Relapses After CAR-T Therapy
    Abbasi, Jennifer
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (18): : 1850 - 1850
  • [24] Target selection for CAR-T therapy
    Jianshu Wei
    Xiao Han
    Jian Bo
    Weidong Han
    Journal of Hematology & Oncology, 12
  • [25] Gut microbiome and CAR-T therapy
    Abid, Muhammad Bilal
    Shah, Nirav N.
    Maatman, Theresa C.
    Hari, Parameswaran N.
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2019, 8 (01)
  • [26] Recent Advances in CAR-T Therapy
    Ali, Meher Binte
    CANCER CONTROL, 2024, 31
  • [27] Gut microbiome and CAR-T therapy
    Muhammad Bilal Abid
    Nirav N. Shah
    Theresa C. Maatman
    Parameswaran N. Hari
    Experimental Hematology & Oncology, 8
  • [28] The Application of Nanobody in CAR-T Therapy
    Bao, Chaolemeng
    Gao, Quanli
    Li, Lin-Lin
    Han, Lu
    Zhang, Bingxiang
    Ding, Yijin
    Song, Zongpei
    Zhang, Ruining
    Zhang, Jishuai
    Wu, Xian-Hui
    BIOMOLECULES, 2021, 11 (02) : 1 - 18
  • [29] THE MRD STATUS ON DAY 7 AND CD4 COUNT AT 1 MONTH AFTER CAR-T THERAPY ARE PROGNOSTIC INDICATORS IN CAR-T TREATMENTS
    Gao, Li
    Lu, Jun
    Cheng, Shengqin
    Wang, Yuxuan
    Xiao, Peifang
    He, Hailong
    Wang, Yi
    Li, Jie
    Hu, Shaoyan
    BONE MARROW TRANSPLANTATION, 2024, 59 : 14 - 14
  • [30] CAR-T Cells
    Maloney, David G.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S100 - S101